08/19/2014 - 10:07am

Walgreens on Tuesday announced that flu shots are now available at all locations, including pharmacies and Healthcare Clinics.

 

08/18/2014 - 11:04am

Americans aspire to be healthier by making better food choices, but admit that the saying is a lot easier than the doing, according to a new white paper titled "Health and Wellness in America" released by Nielsen and the Natural Marketing Institute last week. 

08/18/2014 - 9:55am

The Food and Drug Administration will be hosting an all-day hearing on Sept. 17 seeking public comment on five draft guidance documents related to the implementation of the Generic Drug User Fee Amendments of 2012, as well as input on future policy priorities. 

08/14/2014 - 1:38pm

Amneal Pharmaceuticals announced four new additions to its portfolio of generic drugs, which represent multiple therapeutic categories and account for $900 million annually in U.S. sales, the company said, citing data from IMS Health.

08/13/2014 - 4:44pm

The European Union is leading an international pilot project through which, upon request from a generic pharmaceutical company, it will share the assessment reports generated as part of the decentralized procedure in real time with collaborating regulatory agencies outside the EU.

08/12/2014 - 10:15am

Sanofi on Tuesday announced that it has launched an authorized generic version of Eloxatin (oxaliplatin injection) through Winthrop U.S., the company’s generics division. 

08/12/2014 - 10:08am

Rite Aid is getting a head start on the 2014-15 cold and flu season with the announcement Tuesday that seasonal flu shots are now available at Rite Aid pharmacies nationwide. 

 

08/11/2014 - 4:15pm

Fred's Super Dollar and Cardinal Health on Monday announced a multi-year agreement for Cardinal Health to be the new primary supplier of branded and generic pharmaceutical products.

08/11/2014 - 11:34am

The Food and Drug Administration last week released a draft guidance to assist sponsors and other interested parties in providing information that will help the agency determine the exclusivity period for biologics approved under Section 351(a) of the Public Health Service Act, Bloomberg BNA reported.